.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies.".
more stories from investigations
.

.
.

.

18 hours ago.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.. , et bureau
| .
u.s. first lady melania trump has been in the hospital for four days, with no word on exactly when she will be released..